US FDA approves Gilead’s antiviral remdesivir for treatment of COVID-19.
Based on the strength of data, Veklury (remdesivir) has become the standard of care for the treatment of COVID-19 in hospitalized patients. Remdesivir can speed up recovery time and lesson rates of progression to mechanical ventilation while providing critical hope to loved ones and healthcare providers.
Recent Posts
The priorities of the Center are to provide accessible, patient valued, quality health care by providing unique information systems and developing unique strategies for patients, physicians, other providers, and companies to ensure success in healthcare and business.